CPG 7909, an Immunostimulatory TLR9 Agonist Oligodeoxynucleotide, as Adjuvant to Engerix-B® HBV Vaccine in Healthy Adults: A Double-Blind Phase I/II Study

Author： COOPER C.L.   DAVIS H.L.   MORRIS M.L.   EFLER S.M.   ADHAMI M.   KRIEG A.M.   CAMERON D.W.   HEATHCOTE J.  

Publisher： Springer Publishing Company

ISSN： 0271-9142

Source： Journal of Clinical Immunology, Vol.24, Iss.6, 2004-11, pp. : 693-701

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Randomized, Controlled Dose-Finding Phase II Study of the M72/AS01 Candidate Tuberculosis Vaccine in Healthy PPD-Positive Adults

By Montoya Jaime   Solon Juan   Cunanan Soledad   Acosta Luz   Bollaerts Anne   Moris Philippe   Janssens Michel   Jongert Erik   Demoitié Marie-Ange   Mettens Pascal   Gatchalian Salvacion   Vinals Carlota   Cohen Joe   Ofori-Anyinam Opokua  

Journal of Clinical Immunology, Vol. 33, Iss. 8, 2013-11 ,pp. : 1360-1375

Springer Publishing Company

Access to resources Recommend Favorite

Synthetic oligodeoxynucleotide containing CpG motif induces an anti-polysaccharide type 1-like immune response after immunization of mice with Haemophilus influenzae type b conjugate vaccine

By von Hunolstein C.   Teloni R.   Mariotti S.   Recchia S.   Orefici G.   Nisini R.  

International Immunology, Vol. 12, Iss. 3, 2000-03 ,pp. : 295-303

Oxford University Press

Access to resources Recommend Favorite

A phase I/II study of ofatumumab (GSK1841157) in Japanese and Korean patients with relapsed or refractory B-cell chronic lymphocytic leukemia

By Ogawa Yoshiaki   Ogura Michinori   Suzuki Tatsuya   Ando Kiyoshi   Uchida Toshiki   Shirasugi Yukari   Tobinai Kensei   Lee Je   Kase Masazumi   Katsura Koichi   Hotta Tomomitsu  

International Journal of Hematology, Vol. 98, Iss. 2, 2013-08 ,pp. : 164-170

Springer Publishing Company

Access to resources Recommend Favorite

Erratum to: A phase I/II study of ofatumumab (GSK1841157) in Japanese and Korean patients with relapsed or refractory B-cell chronic lymphocytic leukemia

By Ogawa Yoshiaki   Ogura Michinori   Suzuki Tatsuya   Ando Kiyoshi   Uchida Toshiki   Shirasugi Yukari   Tobinai Kensei   Lee Je   Kase Masazumi   Katsura Koichi   Hotta Tomomitsu  

International Journal of Hematology, Vol. 99, Iss. 3, 2014-03 ,pp. : 354-355

Springer Publishing Company

Access to resources Recommend Favorite

Development of Tumor B-cell Lymphocyte Hybridoma (TBH) Autovaccination. Results of a Phase I-II Clinical Trial

By Moviglia G.A.  

Transfusion and Apheresis Science, Vol. 17, Iss. 4, 1996-12 ,pp. : 643-649

Elsevier

Access to resources Recommend Favorite